California, USA-based Alto Neuroscience saw its shares shoot up more than 80% to $11.00 yesterday, after it revealed it has ...

US contract manufacturer Life Science Outsourcing has appointed Doug Constable as chief executive to steer its next growth ...

South Korea’s SK Biopharmaceuticals (KRX: 326030) has partnered with Brazil’s Eurofarma to launch Mentis Care, a ...

Swiss pharma giant Roche’s US subsidiary Genentech yesterday revealed that the US Food and Drug Administration (FDA) has ...

Five months after closing its Series B financing, USA-based NewLimit has raised an additional $45 million from Eli Lilly), ...

Summit Therapeutics (Nasdaq: SMMT) said it plans to file a biologics license application in the fourth quarter for ...

Israeli pharma major Teva (NYSE: TEVA) has entered a licensing agreement with Singapore-based Prestige Biopharma (KOSDAQ: ...

Danish allergy immunotherapy specialist ALK Abello has announced that EURneffy 2mg nasal adrenaline spray, the UK’s first ...

US biotech Exelixis has announced detailed results from STELLAR-303, a global Phase III pivotal trial evaluating ...

San Diego-based Rani Therapeutics Holdings, a biotherapeutics company focused on the oral delivery of biologics and drugs, ...

Swedish Orphan Biovitrum, the Nordic biotech company also known as Sobi, today announced positive third-quarter 2025 ...

In 2014, I sat in a room at a “Genetic Networks” conference listening to Brendan Frey present his talk titled Decoding the ...